Third Quarter Fiscal 2022 GAAP Results | Third Quarter Fiscal 2022 Non-GAAP Results(1) | ||||||||||||||||
Amount (millions) | Year/Year Growth | ||||||||||||||||
Product revenue | $312.5 | 110 | % | ||||||||||||||
Amount (millions) | Margin | Amount (millions) | Margin | ||||||||||||||
Product gross profit | $220.2 | 70 | % | $233.2 | 75 | % | |||||||||||
Operating income (loss) | ($157.3) | (47 | %) | $8.5 | 3 | % | |||||||||||
Net cash provided by operating activities | $15.5 | ||||||||||||||||
Free cash flow | $9.5 | 3 | % | ||||||||||||||
Adjusted free cash flow | $21.5 | 6 | % | ||||||||||||||
(1) We report non-GAAP financial measures in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. See the section titled “Statement Regarding Use of Non-GAAP Financial Measures” for an explanation of non-GAAP financial measures, and the table titled “GAAP to Non-GAAP Reconciliations” for a reconciliation of GAAP to non-GAAP financial measures. Note: Fiscal year ends January 31. Numbers are rounded for presentation purposes. | |||||||||||||||||
Fourth Quarter Fiscal 2022 GAAP Guidance | Fourth Quarter Fiscal 2022 Non-GAAP Guidance(1) | ||||||||||||||||
Amount (millions) | Year/Year Growth | ||||||||||||||||
Product revenue | $345 - $350 | 94 - 96% | |||||||||||||||
Margin | |||||||||||||||||
Operating income | 1 | % | |||||||||||||||
Amount (millions) | |||||||||||||||||
Weighted-average shares used in computing net income per share attributable to common stockholders - diluted(2) | 358 | ||||||||||||||||
(1) We report non-GAAP financial measures in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. See the section titled “Statement Regarding Use of Non-GAAP Financial Measures” for an explanation of non-GAAP financial measures. (2) We may have a non-GAAP net income for the fourth quarter of fiscal 2022. As a result, we are presenting the weighted-average shares used in computing net income per share attributable to common stockholders - diluted in the non-GAAP column of the table above, giving effect to all dilutive securities (stock options, restricted stock units, and employee stock purchase rights under our 2020 Employee Stock Purchase Plan). These dilutive securities would be excluded from the weighted-average shares used in computing net loss per share attributable to common stockholders - diluted if we are in a non-GAAP net loss position. |
Full-Year Fiscal 2022 GAAP Guidance | Full-Year Fiscal 2022 Non-GAAP Guidance(1) | ||||||||||||||||
Amount (millions) | Year/Year Growth | ||||||||||||||||
Product revenue | $1,126 - $1,131 | 103 - 104% | |||||||||||||||
Margin | |||||||||||||||||
Product gross profit | 74 | % | |||||||||||||||
Operating loss | (4 | %) | |||||||||||||||
Adjusted free cash flow | 8 | % | |||||||||||||||
Amount (millions) | |||||||||||||||||
Weighted-average shares used in computing net income per share attributable to common stockholders - diluted(2) | 357 | ||||||||||||||||
(1) We report non-GAAP financial measures in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. See the section titled “Statement Regarding Use of Non-GAAP Financial Measures” for an explanation of non-GAAP financial measures. (2) We may have a non-GAAP net income for full-year fiscal 2022. As a result, we are presenting the weighted-average shares used in computing net income per share attributable to common stockholders - diluted in the non-GAAP column of the table above, giving effect to all dilutive securities (stock options, restricted stock units, and employee stock purchase rights under our 2020 Employee Stock Purchase Plan). These dilutive securities would be excluded from the weighted-average shares used in computing net loss per share attributable to common stockholders - diluted if we are in a non-GAAP net loss position. |
Three Months Ended October 31, | Nine Months Ended October 31, | ||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||
Revenue | $ | 334,441 | $ | 159,624 | $ | 835,553 | $ | 401,584 | |||||||||||||||
Cost of revenue | 120,786 | 66,681 | 324,253 | 159,684 | |||||||||||||||||||
Gross profit | 213,655 | 92,943 | 511,300 | 241,900 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Sales and marketing | 190,971 | 134,727 | 540,678 | 325,267 | |||||||||||||||||||
Research and development | 115,900 | 74,138 | 343,783 | 143,949 | |||||||||||||||||||
General and administrative | 64,055 | 53,532 | 189,846 | 116,224 | |||||||||||||||||||
Total operating expenses | 370,926 | 262,397 | 1,074,307 | 585,440 | |||||||||||||||||||
Operating loss | (157,271) | (169,454) | (563,007) | (343,540) | |||||||||||||||||||
Interest income | 1,985 | 1,517 | 6,787 | 5,654 | |||||||||||||||||||
Other income (expense), net | 1,609 | (519) | 9,867 | (1,561) | |||||||||||||||||||
Loss before income taxes | (153,677) | (168,456) | (546,353) | (339,447) | |||||||||||||||||||
Provision for income taxes | 1,179 | 433 | 1,442 | 720 | |||||||||||||||||||
Net loss | $ | (154,856) | $ | (168,889) | $ | (547,795) | $ | (340,167) | |||||||||||||||
Net loss per share attributable to common stockholders - basic and diluted | $ | (0.51) | $ | (1.01) | $ | (1.84) | $ | (3.63) | |||||||||||||||
Weighted-average shares used in computing net loss per share attributable to common stockholders - basic and diluted | 303,006,685 | 166,868,200 | 297,435,637 | 93,763,599 | |||||||||||||||||||
October 31, 2021 | January 31, 2021 | ||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 935,217 | $ | 820,177 | |||||||
Short-term investments | 2,955,613 | 3,087,887 | |||||||||
Accounts receivable, net | 254,243 | 294,017 | |||||||||
Deferred commissions, current | 42,896 | 32,371 | |||||||||
Prepaid expenses and other current assets | 120,288 | 66,200 | |||||||||
Total current assets | 4,308,257 | 4,300,652 | |||||||||
Long-term investments | 1,211,858 | 1,165,275 | |||||||||
Property and equipment, net | 94,377 | 68,968 | |||||||||
Operating lease right-of-use assets | 184,057 | 186,818 | |||||||||
Goodwill | 8,449 | 8,449 | |||||||||
Intangible assets, net | 26,167 | 16,091 | |||||||||
Deferred commissions, non-current | 101,551 | 86,164 | |||||||||
Other assets | 228,755 | 89,322 | |||||||||
Total assets | $ | 6,163,471 | $ | 5,921,739 | |||||||
Liabilities and Stockholders’ Equity | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 10,559 | $ | 5,647 | |||||||
Accrued expenses and other current liabilities | 163,238 | 125,315 | |||||||||
Operating lease liabilities, current | 25,194 | 19,650 | |||||||||
Deferred revenue, current | 759,744 | 638,652 | |||||||||
Total current liabilities | 958,735 | 789,264 | |||||||||
Operating lease liabilities, non-current | 178,697 | 184,887 | |||||||||
Deferred revenue, non-current | 7,132 | 4,194 | |||||||||
Other liabilities | 12,225 | 6,923 | |||||||||
Stockholders’ equity | 5,006,682 | 4,936,471 | |||||||||
Total liabilities and stockholders’ equity | $ | 6,163,471 | $ | 5,921,739 |
Three Months Ended October 31, | Nine Months Ended October 31, | ||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||||
Net loss | $ | (154,856) | $ | (168,889) | $ | (547,795) | $ | (340,167) | |||||||||||||||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||||||||||||||||||||
Depreciation and amortization | 5,518 | 2,849 | 15,586 | 6,611 | |||||||||||||||||||
Non-cash operating lease costs | 8,855 | 8,503 | 25,895 | 24,840 | |||||||||||||||||||
Amortization of deferred commissions | 9,667 | 7,167 | 26,824 | 21,233 | |||||||||||||||||||
Stock-based compensation, net of amounts capitalized | 144,387 | 119,141 | 459,392 | 157,790 | |||||||||||||||||||
Net amortization of premiums on investments | 11,587 | 891 | 36,938 | 1,117 | |||||||||||||||||||
Unrealized gains on strategic investments in equity securities | (455) | — | (8,515) | — | |||||||||||||||||||
Other | (247) | 24 | 2,535 | 4,073 | |||||||||||||||||||
Changes in operating assets and liabilities, net of effect of business combinations: | |||||||||||||||||||||||
Accounts receivable | (16,754) | (17,908) | 39,142 | 9,221 | |||||||||||||||||||
Deferred commissions | (18,961) | (12,995) | (52,892) | (27,261) | |||||||||||||||||||
Prepaid expenses and other assets | (42,710) | (28,028) | (112,798) | (29,480) | |||||||||||||||||||
Accounts payable | 869 | (963) | 4,591 | (3,806) | |||||||||||||||||||
Accrued expenses and other liabilities | 19,386 | 11,484 | 43,106 | 22,477 | |||||||||||||||||||
Operating lease liabilities | (8,766) | (6,014) | (24,758) | (23,418) | |||||||||||||||||||
Deferred revenue | 58,018 | 64,984 | 124,030 | 111,739 | |||||||||||||||||||
Net cash provided by (used in) operating activities | 15,538 | (19,754) | 31,281 | (65,031) | |||||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||||
Purchases of property and equipment | (2,282) | (17,270) | (12,209) | (24,018) | |||||||||||||||||||
Capitalized internal-use software development costs | (3,788) | (844) | (8,612) | (4,014) | |||||||||||||||||||
Cash paid for business combinations, net of cash acquired | — | — | — | (6,035) | |||||||||||||||||||
Purchases of intangible assets | — | — | (11,182) | (6,184) | |||||||||||||||||||
Purchases of investments | (1,053,763) | (622,385) | (3,042,396) | (1,235,020) | |||||||||||||||||||
Sales of investments | 14,691 | 25,195 | 407,003 | 28,705 | |||||||||||||||||||
Maturities and redemptions of investments | 1,216,206 | 181,669 | 2,610,429 | 371,528 | |||||||||||||||||||
Net cash provided by (used in) investing activities | 171,064 | (433,635) | (56,967) | (875,038) | |||||||||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||||
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | — | — | — | 478,573 | |||||||||||||||||||
Proceeds from initial public offering and private placements, net of underwriting discounts and other offering costs (net of reimbursement received from the underwriters) | — | 4,244,620 | — | 4,242,284 | |||||||||||||||||||
Proceeds from early exercised stock options | — | — | — | 159 | |||||||||||||||||||
Proceeds from exercise of stock options | 24,579 | 10,364 | 90,444 | 31,100 | |||||||||||||||||||
Proceeds from issuance of common stock under the employee stock purchase plan | 25,829 | — | 52,227 | — | |||||||||||||||||||
Proceeds from repayments of a nonrecourse promissory note | — | — | — | 2,090 | |||||||||||||||||||
Repurchases of early exercised stock options | — | — | — | (30) | |||||||||||||||||||
Payments of deferred purchase consideration for business combinations | — | (564) | — | (1,164) | |||||||||||||||||||
Net cash provided by financing activities | 50,408 | 4,254,420 | 142,671 | 4,753,012 | |||||||||||||||||||
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (194) | — | 21 | — | |||||||||||||||||||
Net increase in cash, cash equivalents, and restricted cash | 236,816 | 3,801,031 | 117,006 | 3,812,943 | |||||||||||||||||||
Cash, cash equivalents, and restricted cash at beginning of period | 715,383 | 153,888 | 835,193 | 141,976 | |||||||||||||||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 952,199 | $ | 3,954,919 | $ | 952,199 | $ | 3,954,919 |
Three Months Ended October 31, 2021 | |||||||||||||||||||||||||||||||||||||||||
GAAP amounts | GAAP amounts as a % of revenue | Stock-based compensation expense-related charges(1) | Amortization of acquired intangibles | Expenses associated with acquisitions and strategic investments | Non-GAAP amounts | Non-GAAP amounts as a % of revenue | |||||||||||||||||||||||||||||||||||
Revenue: | |||||||||||||||||||||||||||||||||||||||||
Product revenue | $ | 312,458 | 93 | % | |||||||||||||||||||||||||||||||||||||
Professional services and other revenue | 21,983 | 7 | % | ||||||||||||||||||||||||||||||||||||||
Revenue | 334,441 | 100 | % | ||||||||||||||||||||||||||||||||||||||
Year over Year % Growth | 110 | % | |||||||||||||||||||||||||||||||||||||||
Cost of revenue: | |||||||||||||||||||||||||||||||||||||||||
Cost of product revenue | 92,292 | 28 | % | $ | (12,419) | $ | (567) | $ | — | $ | 79,306 | 24 | % | ||||||||||||||||||||||||||||
Cost of professional services and other revenue | 28,494 | 8 | % | (9,908) | — | — | 18,586 | 5 | % | ||||||||||||||||||||||||||||||||
Total cost of revenue | 120,786 | 36 | % | (22,327) | (567) | — | 97,892 | 29 | % | ||||||||||||||||||||||||||||||||
Gross profit (loss): | |||||||||||||||||||||||||||||||||||||||||
Product gross profit | 220,166 | 12,419 | 567 | — | 233,152 | ||||||||||||||||||||||||||||||||||||
Professional services and other gross profit (loss) | (6,511) | 9,908 | — | — | 3,397 | ||||||||||||||||||||||||||||||||||||
Total gross profit | 213,655 | 64 | % | 22,327 | 567 | — | 236,549 | 71 | % | ||||||||||||||||||||||||||||||||
Product gross margin | 70 | % | 5 | % | — | % | — | % | 75 | % | |||||||||||||||||||||||||||||||
Professional services and other gross margin | (30 | %) | 45 | % | — | % | — | % | 15 | % | |||||||||||||||||||||||||||||||
Total gross margin | 64 | % | 7 | % | — | % | — | % | 71 | % | |||||||||||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||||||||||||||||||
Sales and marketing | 190,971 | 57 | % | (54,098) | — | — | 136,873 | 40 | % | ||||||||||||||||||||||||||||||||
Research and development | 115,900 | 35 | % | (59,693) | (944) | — | 55,263 | 17 | % | ||||||||||||||||||||||||||||||||
General and administrative | 64,055 | 19 | % | (27,668) | (411) | (35) | 35,941 | 11 | % | ||||||||||||||||||||||||||||||||
Total operating expenses | 370,926 | 111 | % | (141,459) | (1,355) | (35) | 228,077 | 68 | % | ||||||||||||||||||||||||||||||||
Operating income (loss) | $ | (157,271) | (47 | %) | $ | 163,786 | $ | 1,922 | $ | 35 | $ | 8,472 | 3 | % | |||||||||||||||||||||||||||
Operating margin | (47 | %) | 49 | % | 1 | % | — | % | 3 | % | |||||||||||||||||||||||||||||||
(1) Stock-based compensation expense-related charges included approximately $19.1 million of employer payroll tax-related expenses on employee stock transactions. | |||||||||||||||||||||||||||||||||||||||||
Three Months Ended October 31, 2020 | |||||||||||||||||||||||||||||||||||||||||
GAAP amounts | GAAP amounts as a % of revenue | Stock-based compensation expense-related charges(1) | Amortization of acquired intangibles | Expenses associated with acquisitions and strategic investments | Non-GAAP amounts | Non-GAAP amounts as a % of revenue | |||||||||||||||||||||||||||||||||||
Revenue: | |||||||||||||||||||||||||||||||||||||||||
Product revenue | $ | 148,473 | 93 | % | |||||||||||||||||||||||||||||||||||||
Professional services and other revenue | 11,151 | 7 | % | ||||||||||||||||||||||||||||||||||||||
Revenue | 159,624 | 100 | % | ||||||||||||||||||||||||||||||||||||||
Year over Year % Growth | 119 | % | |||||||||||||||||||||||||||||||||||||||
Cost of revenue: | |||||||||||||||||||||||||||||||||||||||||
Cost of product revenue | 51,816 | 32 | % | $ | (7,325) | $ | (567) | $ | — | $ | 43,924 | 28 | % | ||||||||||||||||||||||||||||
Cost of professional services and other revenue | 14,865 | 10 | % | (6,203) | — | — | 8,662 | 5 | % | ||||||||||||||||||||||||||||||||
Total cost of revenue | 66,681 | 42 | % | (13,528) | (567) | — | 52,586 | 33 | % | ||||||||||||||||||||||||||||||||
Gross profit (loss): | |||||||||||||||||||||||||||||||||||||||||
Product gross profit | 96,657 | 7,325 | 567 | — | 104,549 | ||||||||||||||||||||||||||||||||||||
Professional services and other gross profit (loss) | (3,714) | 6,203 | — | — | 2,489 | ||||||||||||||||||||||||||||||||||||
Total gross profit | 92,943 | 58 | % | 13,528 | 567 | — | 107,038 | 67 | % | ||||||||||||||||||||||||||||||||
Product gross margin | 65 | % | 5 | % | — | % | — | % | 70 | % | |||||||||||||||||||||||||||||||
Professional services and other gross margin | (33 | %) | 55 | % | — | % | — | % | 22 | % | |||||||||||||||||||||||||||||||
Total gross margin | 58 | % | 9 | % | — | % | — | % | 67 | % | |||||||||||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||||||||||||||||||
Sales and marketing | 134,727 | 84 | % | (40,337) | — | — | 94,390 | 59 | % | ||||||||||||||||||||||||||||||||
Research and development | 74,138 | 46 | % | (39,406) | — | — | 34,732 | 22 | % | ||||||||||||||||||||||||||||||||
General and administrative | 53,532 | 34 | % | (27,197) | (309) | — | 26,026 | 16 | % | ||||||||||||||||||||||||||||||||
Total operating expenses | 262,397 | 164 | % | (106,940) | (309) | — | 155,148 | 97 | % | ||||||||||||||||||||||||||||||||
Operating loss | $ | (169,454) | (106 | %) | $ | 120,468 | $ | 876 | $ | — | $ | (48,110) | (30 | %) | |||||||||||||||||||||||||||
Operating margin | (106 | %) | 76 | % | — | % | — | % | (30 | %) | |||||||||||||||||||||||||||||||
(1) Stock-based compensation expense-related charges included approximately $1.1 million of employer payroll tax-related expenses on employee stock transactions. |
Nine Months Ended October 31, 2021 | |||||||||||||||||||||||||||||||||||||||||
GAAP amounts | GAAP amounts as a % of revenue | Stock-based compensation expense-related charges(1) | Amortization of acquired intangibles | Expenses associated with acquisitions and strategic investments | Non-GAAP amounts | Non-GAAP amounts as a % of revenue | |||||||||||||||||||||||||||||||||||
Revenue: | |||||||||||||||||||||||||||||||||||||||||
Product revenue | $ | 780,911 | 93 | % | |||||||||||||||||||||||||||||||||||||
Professional services and other revenue | 54,642 | 7 | % | ||||||||||||||||||||||||||||||||||||||
Revenue | 835,553 | 100 | % | ||||||||||||||||||||||||||||||||||||||
Year over Year % Growth | 108 | % | |||||||||||||||||||||||||||||||||||||||
Cost of revenue: | |||||||||||||||||||||||||||||||||||||||||
Cost of product revenue | 245,420 | 29 | % | $ | (37,813) | $ | (1,700) | $ | — | $ | 205,907 | 25 | % | ||||||||||||||||||||||||||||
Cost of professional services and other revenue | 78,833 | 10 | % | (31,941) | — | — | 46,892 | 5 | % | ||||||||||||||||||||||||||||||||
Total cost of revenue | 324,253 | 39 | % | (69,754) | (1,700) | — | 252,799 | 30 | % | ||||||||||||||||||||||||||||||||
Gross profit (loss): | |||||||||||||||||||||||||||||||||||||||||
Product gross profit | 535,491 | 37,813 | 1,700 | — | 575,004 | ||||||||||||||||||||||||||||||||||||
Professional services and other gross profit (loss) | (24,191) | 31,941 | — | — | 7,750 | ||||||||||||||||||||||||||||||||||||
Total gross profit | 511,300 | 61 | % | 69,754 | 1,700 | — | 582,754 | 70 | % | ||||||||||||||||||||||||||||||||
Product gross margin | 69 | % | 5 | % | — | % | — | % | 74 | % | |||||||||||||||||||||||||||||||
Professional services and other gross margin | (44 | %) | 58 | % | — | % | — | % | 14 | % | |||||||||||||||||||||||||||||||
Total gross margin | 61 | % | 9 | % | — | % | — | % | 70 | % | |||||||||||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||||||||||||||||||
Sales and marketing | 540,678 | 65 | % | (165,969) | — | — | 374,709 | 45 | % | ||||||||||||||||||||||||||||||||
Research and development | 343,783 | 40 | % | (186,346) | (2,741) | — | 154,696 | 19 | % | ||||||||||||||||||||||||||||||||
General and administrative | 189,846 | 23 | % | (85,624) | (1,209) | (431) | 102,582 | 12 | % | ||||||||||||||||||||||||||||||||
Total operating expenses | 1,074,307 | 128 | % | (437,939) | (3,950) | (431) | 631,987 | 76 | % | ||||||||||||||||||||||||||||||||
Operating loss | $ | (563,007) | (67 | %) | $ | 507,693 | $ | 5,650 | $ | 431 | $ | (49,233) | (6 | %) | |||||||||||||||||||||||||||
Operating margin | (67 | %) | 60 | % | 1 | % | — | % | (6 | %) | |||||||||||||||||||||||||||||||
(1) Stock-based compensation expense-related charges included approximately $47.4 million of employer payroll tax-related expenses on employee stock transactions. | |||||||||||||||||||||||||||||||||||||||||
Nine Months Ended October 31, 2020 | |||||||||||||||||||||||||||||||||||||||||
GAAP amounts | GAAP amounts as a % of revenue | Stock-based compensation expense-related charges(1) | Amortization of acquired intangibles | Expenses associated with acquisitions and strategic investments | Non-GAAP amounts | Non-GAAP amounts as a % of revenue | |||||||||||||||||||||||||||||||||||
Revenue: | |||||||||||||||||||||||||||||||||||||||||
Product revenue | $ | 375,506 | 94 | % | |||||||||||||||||||||||||||||||||||||
Professional services and other revenue | 26,078 | 6 | % | ||||||||||||||||||||||||||||||||||||||
Revenue | 401,584 | 100 | % | ||||||||||||||||||||||||||||||||||||||
Year over Year % Growth | 127 | % | |||||||||||||||||||||||||||||||||||||||
Cost of revenue: | |||||||||||||||||||||||||||||||||||||||||
Cost of product revenue | 130,065 | 32 | % | $ | (8,553) | $ | (1,130) | $ | — | $ | 120,382 | 30 | % | ||||||||||||||||||||||||||||
Cost of professional services and other revenue | 29,619 | 8 | % | (7,402) | — | — | 22,217 | 6 | % | ||||||||||||||||||||||||||||||||
Total cost of revenue | 159,684 | 40 | % | (15,955) | (1,130) | — | 142,599 | 36 | % | ||||||||||||||||||||||||||||||||
Gross profit (loss): | |||||||||||||||||||||||||||||||||||||||||
Product gross profit | 245,441 | 8,553 | 1,130 | — | 255,124 | ||||||||||||||||||||||||||||||||||||
Professional services and other gross profit (loss) | (3,541) | 7,402 | — | — | 3,861 | ||||||||||||||||||||||||||||||||||||
Total gross profit | 241,900 | 60 | % | 15,955 | 1,130 | — | 258,985 | 64 | % | ||||||||||||||||||||||||||||||||
Product gross margin | 65 | % | 3 | % | — | % | — | % | 68 | % | |||||||||||||||||||||||||||||||
Professional services and other gross margin | (14 | %) | 29 | % | — | % | — | % | 15 | % | |||||||||||||||||||||||||||||||
Total gross margin | 60 | % | 4 | % | — | % | — | % | 64 | % | |||||||||||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||||||||||||||||||
Sales and marketing | 325,267 | 81 | % | (52,099) | (12) | — | 273,156 | 68 | % | ||||||||||||||||||||||||||||||||
Research and development | 143,949 | 36 | % | (50,514) | — | — | 93,435 | 23 | % | ||||||||||||||||||||||||||||||||
General and administrative | 116,224 | 29 | % | (43,934) | (717) | (252) | 71,321 | 18 | % | ||||||||||||||||||||||||||||||||
Total operating expenses | 585,440 | 146 | % | (146,547) | (729) | (252) | 437,912 | 109 | % | ||||||||||||||||||||||||||||||||
Operating loss | $ | (343,540) | (86 | %) | $ | 162,502 | $ | 1,859 | $ | 252 | $ | (178,927) | (45 | %) | |||||||||||||||||||||||||||
Operating margin | (86 | %) | 41 | % | — | % | — | % | (45 | %) | |||||||||||||||||||||||||||||||
(1) Stock-based compensation expense-related charges included approximately $4.5 million of employer payroll tax-related expenses on employee stock transactions. | |||||||||||||||||||||||||||||||||||||||||
Three Months Ended October 31, | Nine Months Ended October 31, | ||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||
Revenue | $ | 334,441 | $ | 159,624 | $ | 835,553 | $ | 401,584 | |||||||||||||||
GAAP net cash provided by (used in) operating activities | $ | 15,538 | $ | (19,754) | $ | 31,281 | $ | (65,031) | |||||||||||||||
Less: purchases of property and equipment | (2,282) | (17,270) | (12,209) | (24,018) | |||||||||||||||||||
Less: capitalized internal-use software development costs | (3,788) | (844) | (8,612) | (4,014) | |||||||||||||||||||
Non-GAAP free cash flow | 9,468 | (37,868) | 10,460 | (93,063) | |||||||||||||||||||
Add: net cash paid on payroll tax-related items on employee stock transactions | 12,058 | 812 | 37,267 | 4,196 | |||||||||||||||||||
Non-GAAP adjusted free cash flow | $ | 21,526 | $ | (37,056) | $ | 47,727 | $ | (88,867) | |||||||||||||||
Non-GAAP free cash flow margin | 3 | % | (24 | %) | 1 | % | (23 | %) | |||||||||||||||
Non-GAAP adjusted free cash flow margin | 6 | % | (23 | %) | 6 | % | (22 | %) | |||||||||||||||